ADA2 genotype and enzyme activity may predict vasculitic or hematologic DADA2 phenotype. [PDF]
Peters P +38 more
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
God In France: Eight Contemporary French Thinkers on God, edited by Jonkers, P. & R. Welten
Nathan Loewen
openalex +2 more sources
Leaders of the Communist World. Edited by Rodger Swearingen. New York: Free Press. London: Collier-Macmillan, 1971. xv, 632 pp. $17,95. [PDF]
Bernard S. Morris
openalex +1 more source
ASEAS Redaktion / ASEAS Editing Board
doaj
Compte-rendu de Journée d’étude : Frederick Wiseman, « Ordre et résistance »
Youri Borg, Damien Sarroméjean
doaj +1 more source
Therapeutic adenine base editor with minimized off-target effects. [PDF]
Sun Y +6 more
europepmc +1 more source
Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu +13 more
wiley +1 more source
Neuromuscular Diseases: From Basic Mechanisms to Clinical Management. Monographs in Clinical Neurosciences: Vol. 18. 2000. Edited by F. Deymeer. Published by Karger. 196 pages. C$241.00 approx. [PDF]
George Karpati
openalex +1 more source

